Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $56.4619 (0.7%) ($55.9115 - $56.5582) on Tue. Oct. 25, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.88% (three month average) | RSI | 40 | Latest Price | $56.4619(0.7%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV declines -0.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(49%) IVE(47%) IWD(46%) SPY(46%) | Factors Impacting ABBV price | ABBV will decline at least -0.44% in a week (0% probabilities). VIXM(-18%) TLT(-14%) UUP(-9%) IPO(-4%) IGOV(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.44% (StdDev 0.88%) | Hourly BBV | 0 () | Intraday Trend | 0.8% | | | |
|
Resistance Level | $56.68 | 5 Day Moving Average | $56.29(0.31%) | 10 Day Moving Average | $56.07(0.7%) | 20 Day Moving Average | $56.68(-0.38%) | To recent high | -7.8% | To recent low | 2.3% | Market Cap | $99.615b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |